The discovery of the mTOR signaling pathway was of particular interest because the application of PI3K-Akt-mTOR signaling axis to COVID-19 disease and to other chronic conditions, such as obesity, has been reported [48,49]. Here, AKT1 is linked to obesity due to melanocortin 4 receptor deficiency.